Wildon Farwell is Chief Medical Officer at Dyne Therapeutics, Inc. (DYN). They have made 1 open-market trade across 1 company since 2022, most recently 2024-08-19.
CIK 0001847941
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DYN | 143,483 | $2.0M |
Shares reported on the most recent Form 4, priced at the 2024-08-20 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DYN | SELL · 10b5-1 | 2024-08-19 | 2024-08-20 | $45.07 | $197K | -0.8% | -21.7% | -36.9% |
| DYN | SELL · 10b5-1 | 2024-06-11 | 2024-06-11 | $31.27 | $133K | +9.5% | +29.0% | -0.2% |
| DYN | SELL · 10b5-1 | 2024-05-16 | 2024-05-17 | $28.24 | $122K | -1.6% | +0.3% | +44.3% |
| DYN | SELL · 10b5-1 | 2024-03-11 | 2024-03-12 | $25.65 | $67K | +3.9% | +0.8% | +15.9% |
| DYN | SELL · 10b5-1 | 2024-03-07 | 2024-03-11 | $25.83 | $472K | +15.1% | +5.8% | +24.3% |
| DYN | SELL · 10b5-1 | 2024-02-28 | 2024-02-28 | $25.00 | $10K | -0.4% | +9.1% | +17.0% |
| DYN | SELL · 10b5-1 | 2024-02-12 | 2024-02-14 | $25.07 | $275K | +1.5% | +15.5% | +16.2% |
| DYN | SELL · 10b5-1 | 2024-01-26 | 2024-01-26 | $25.00 | $3K | +3.1% | +15.6% | +13.9% |
| DYN | SELL · 10b5-1 | 2023-12-11 | 2023-12-12 | $10.66 | $28K | +15.6% | +50.0% | +133.5% |
| DYN | SELL · 10b5-1 | 2023-09-12 | 2023-09-13 | $10.41 | $18K | -6.1% | -11.6% | +18.7% |
| DYN | SELL · 10b5-1 | 2023-06-13 | 2023-06-14 | $12.43 | $21K | -16.1% | -9.9% | -19.6% |
| DYN | SELL | 2023-03-14 | 2023-03-15 | $13.33 | $198K | -13.0% | -27.2% | +3.0% |
| DYN | SELL · 10b5-1 | 2022-12-12 | 2022-12-13 | $10.87 | $7K | -2.0% | -4.7% | +5.4% |
| DYN | SELL · 10b5-1 | 2022-03-11 | 2022-03-14 | $8.73 | $6K | +3.0% | +9.2% | -44.6% |
| DYN | SELL · 10b5-1 | 2022-03-02 | 2022-03-03 | $8.56 | $48K | +5.2% | +27.9% | -46.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.